Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 9, 2005

View Archived Issues

PET scans may help predict response to therapy in metastatic breast cancer

Inhaled insulin shows promise as an alternative to subcutaneous insulin in type 1 diabetes

Novartis reflects on Q2 activities

Thymitaq phase III study fails to meet primary endpoint

Phase IIb studies begin for PT-141 for erectile dysfunction

Two more sites join Canadian phase II study of ADH-1

Par terminates amoxicillin partnership with Advancis

Characterization of a novel VRAC inhibitor for heart disease

KBMA vaccines: novel strategy for safe protective immunity

SB-706375: novel nonpeptidic UT receptor antagonist

Antithrombotic activity of DU-176b described in several animal models

Data describing pharmacodynamic profile of TGN-255 presented

Biogen Idec and PDL form collaboration for antibody products

Novel immunomodulatory agents disclosed in recent patents

Novel agents for thrombotic disorders prepared and tested

Novel agents for treating ADHD in early development at PsychoGenics

Novel MRI agents imparted by General Hospital Corporation

Santhera and Takeda to collaborate on idebenone for Friedreich's ataxia

Pozen discontinues MT-100 development in U.S. following FDA review

Pozen submits Trexima NDA for migraine

HIV protease inhibitors have potential efficacy against opportunistic leishmaniasis infections

European orphan drug status recommended for Amplimexon

Rohto to acquire Bayer Yakuhin research center

AstraZeneca and Astex Therapeutics partner on PKB inhibitors for cancer

ISIS-301012 reduces LDL cholesterol in phase I study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...